Warning: The NCBI web site requires JavaScript to function. more...
A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation.
Beretta L, Cossu M, Marchini M, Cappiello F, Artoni A, Motta G, Scorza R.
Arthritis Res Ther. 2008;10(5):R103. Epub 2008 Sep 1.
Related citations
5-Hydroxytryptamine-2A receptor gene (HTR 2 A) candidate polymorphism (T 102 C): Role for human platelet function under pharmacological challenge ex vivo.
Ozdener F, Gülbas Z, Erol K, Ozdemir V.
Methods Find Exp Clin Pharmacol. 2005 Jul-Aug;27(6):395-400.
Inter-relationships of intermediate phenotypes for serotonin function, impulsivity, and a 5-HT2A candidate allele: His452Tyr.
Reist C, Mazzanti C, Vu R, Fujimoto K, Goldman D.
Mol Psychiatry. 2004 Sep;9(9):871-8.
5HT2A polymorphism His452Tyr in a German Caucasian systemic sclerosis population.
Kirsten H, Burkhardt J, Hantmann H, Hunzelmann N, Vaith P, Ahnert P, Melchers I.
Arthritis Res Ther. 2009;11(2):403; author reply 404. Epub 2009 Mar 26. No abstract available.
Serotonin-2A receptor gene polymorphisms are associated with serotonin-induced platelet aggregation.
Shimizu M, Kanazawa K, Matsuda Y, Takai E, Iwai C, Miyamoto Y, Hashimoto M, Akita H, Yokoyama M.
Thromb Res. 2003;112(3):137-42. No abstract available.
A polymorphism in the CTGF promoter region associated with systemic sclerosis.
Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, Spagnolo P, Pantelidis P, Leoni P, McHugh N, Stock CJ, Shi-Wen X, Denton CP, Black CM, Welsh KI, du Bois RM, Abraham DJ.
N Engl J Med. 2007 Sep 20;357(12):1210-20.
Association study of two polymorphisms of the serotonin-2A receptor gene and suicide attempts.
Vaquero-Lorenzo C, Baca-Garcia E, Diaz-Hernandez M, Perez-Rodriguez MM, Fernandez-Navarro P, Giner L, Carballo JJ, Saiz-Ruiz J, Fernandez-Piqueras J, Baldomero EB, de Leon J, Oquendo MA.
Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):645-9.
Serotonin induced platelet aggregation in systemic sclerosis.
Friedhoff LT, Seibold JR, Kim HC, Simester KS.
Clin Exp Rheumatol. 1984 Apr-Jun;2(2):119-23.
A novel variant in the platelet endothelial aggregation receptor-1 gene is associated with increased platelet aggregability.
Herrera-Galeano JE, Becker DM, Wilson AF, Yanek LR, Bray P, Vaidya D, Faraday N, Becker LC.
Arterioscler Thromb Vasc Biol. 2008 Aug;28(8):1484-90. Epub 2008 May 29.
Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link?
Schins A, Honig A, Crijns H, Baur L, Hamulyák K.
Psychosom Med. 2003 Sep-Oct;65(5):729-37. Review.
Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
Gómez-Gil E, Gastó C, Díaz-Ricart M, Carretero M, Salamero M, Catalán R, Escolar G.
Hum Psychopharmacol. 2002 Dec;17(8):419-24.
Association of the 5-HT2A receptor gene polymorphism 102T/C with ischemic stroke.
Olesen OF, Bennike B, Dam H, Mellerup E.
J Mol Neurosci. 2006;30(3):323-8.
Endothelin axis polymorphisms in patients with scleroderma.
Fonseca C, Renzoni E, Sestini P, Pantelidis P, Lagan A, Bunn C, McHugh N, Welsh KI, Du Bois RM, Denton CP, Black C, Abraham D.
Arthritis Rheum. 2006 Sep;54(9):3034-42.
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.
Shuldiner AR, O'Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, Pollin TI, Post W, Parsa A, Mitchell BD, Faraday N, Herzog W, Gurbel PA.
JAMA. 2009 Aug 26;302(8):849-57.
Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis.
Balada E, Simeón-Aznar CP, Serrano-Acedo S, Martínez-Lostao L, Selva-O'Callaghan A, Fonollosa-Pla V, Vilardell-Tarrés M.
Clin Exp Rheumatol. 2006 May-Jun;24(3):321-4.
Decrease of the platelet 5-HT2A receptor function by long-term imipramine treatment in endogenous depression.
Gómez-Gil E, Gastó C, Carretero M, Díaz-Ricart M, Salamero M, Navinés R, Escolar G.
Hum Psychopharmacol. 2004 Jun;19(4):251-8.
A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis.
Abdallah AM, Renzoni EA, Anevlavis S, Lagan AL, Munkonge FM, Fonseca C, Black CM, Briggs D, Wells AU, Marshall SE, McHugh N, du Bois RM, Welsh KI.
Int J Immunogenet. 2006 Jun;33(3):155-61.
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis.
Dieudé P, Guedj M, Wipff J, Avouac J, Fajardy I, Diot E, Granel B, Sibilia J, Cabane J, Mouthon L, Cracowski JL, Carpentier PH, Hachulla E, Meyer O, Kahan A, Boileau C, Allanore Y.
Arthritis Rheum. 2009 Jan;60(1):225-33.
Study of V1a vasopressin receptor gene single nucleotide polymorphisms in platelet vasopressin responsiveness.
Hasan KN, Shoji M, Tsutaya S, Kudo R, Matsuda E, Saito J, Kimura T, Yasujima M.
J Clin Lab Anal. 2006;20(3):87-92.
In vitro platelet aggregability studies: lack of evidence for platelet hyperactivity in systemic sclerosis.
Price JE, Klimiuk PS, Jayson MI.
Ann Rheum Dis. 1991 Aug;50(8):567-71.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on